← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 3, 2021Last known activity
Jul 1, 2025
Timeline
2000s
- Jun 1, 2007
Viridian Therapeutics— Founded
2020s
- Oct 15, 2020
miRagen Therapeutics, Inc.— Acquired
Drugs by trial phase (8 distinct, 14 trials)
Phase 2 (0 own, 3 via acquisition)
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (9)
- NCT07155668Lead sponsorPhase 3Jul 1, 2025
- NCT06812325Lead sponsorPhase 3Feb 28, 2025
- NCT06625411Lead sponsorPhase 3Aug 27, 2024
- NCT06625398Lead sponsorPhase 3Aug 27, 2024
- NCT06384547Lead sponsorPhase 3May 23, 2024
- NCT06179875Lead sponsorPhase 3Dec 31, 2023
- NCT06021054Lead sponsorPhase 3Nov 14, 2023
- NCT05176639Lead sponsorPhase 2/Phase 3Dec 3, 2021
- NCT05176639Study directorPhase 2/Phase 3Dec 3, 2021
Details
- Founded
- Denver, CO, US Jun 1, 2007
- Last known activity
- Jul 1, 2025